Your browser doesn't support javascript.
loading
E2F2 enhances the chemoresistance of pancreatic cancer to gemcitabine by regulating the cell cycle and upregulating the expression of RRM2.
Liu, Qianfan; Song, Chunzhuo; Li, Junjun; Liu, Meng; Fu, Liyue; Jiang, Jiuliang; Zeng, Zhirui; Zhu, Haitao.
Afiliação
  • Liu Q; Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550001, Guizhou, People's Republic of China.
  • Song C; Department of General Surgery, Northern Jiangsu People's Hospital, Yangzhou, 225000, Jiangsu Province, People's Republic of China.
  • Li J; Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550001, Guizhou, People's Republic of China.
  • Liu M; Department of Hepatobiliary Surgery, The Second Affiliated Hospital, Army Medical University, Chongqing, 400037, People's Republic of China.
  • Fu L; Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550001, Guizhou, People's Republic of China.
  • Jiang J; Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550001, Guizhou, People's Republic of China.
  • Zeng Z; Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550001, Guizhou, People's Republic of China.
  • Zhu H; Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550001, Guizhou, People's Republic of China.
Med Oncol ; 39(9): 124, 2022 Jun 18.
Article em En | MEDLINE | ID: mdl-35716217
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Resistencia a Medicamentos Antineoplásicos / Desoxicitidina / Fator de Transcrição E2F2 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Med Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Resistencia a Medicamentos Antineoplásicos / Desoxicitidina / Fator de Transcrição E2F2 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Med Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos